All AbMole products are for research use only, cannot be used for human consumption.
XAV939 is an inhibitor of Tankryases with IC50 values of 11 and 4nM for Tankyrase 1 and Tankyrase 2, respectively. It stimulates beta-catenin degradation by stabilizing axin, resulting in the inhibition of the canonical Wnt pathway. Wnt proteins act on a variety of stem cells that include neural, mammary and embryonic stem cells. XAV939 increases the protein levels of the axin-GSK3β complex and promotes the degradation of β-catenin in SW480 cells. In addition, XAV939 inhibits growth of DLD-1 cells, an APC-deficient colorectal cancer cell line.
Biochem Pharmacol. 2023 Jun;212:115582.
Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT
XAV939 purchased from AbMole
Stem Cell Rev Rep. 2022 Aug;18(6):2059-2073.
Adipose Mesenchymal Stem Cell-Derived Exosomes Promote Wound Healing Through the WNT/β-catenin Signaling Pathway in Dermal Fibroblasts
XAV939 purchased from AbMole
Dis Markers. 2022 Jun 2;2022:5772089.
Overexpression of Activating Transcription Factor-2 (ATF-2) Activates Wnt/Ca 2+ Signaling Pathways and Promotes Proliferation and Invasion in Non-Small-Cell Lung Cancer
XAV939 purchased from AbMole
Open Med (Wars). 2022 Apr 13;17(1):741-755.
Notoginsenoside R1 alleviates spinal cord injury through the miR-301a/KLF7 axis to activate Wnt/β-catenin pathway
XAV939 purchased from AbMole
Neural Plast. 2021 Apr 19;2021:6680192.
The Wnt/ β-Catenin Pathway Regulated Cytokines for Pathological Neuropathic Pain in Chronic Compression of Dorsal Root Ganglion Model
XAV939 purchased from AbMole
EBioMedicine. 2020 Jan 14.
Systematic Investigation on Multi-Scale Mechanisms of Astragaloside IV in Treating Diabetic Nephropathy
XAV939 purchased from AbMole
Pharmacol Res. 2020 Jul;157:104831.
Astragaloside IV acts through multi-scale mechanisms to effectively reduce diabetic nephropathy
XAV939 purchased from AbMole
Stem Cell Res. 2020 Mar;43:101698.
Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties.
XAV939 purchased from AbMole
Cell Communication & Signaling. 2020 Sep 10.
JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level
XAV939 purchased from AbMole
Eur Rev Med Pharmacol Sci. 2017 Apr;21(8):1980-1989.
Isoflurane and sevoflurane affects Wnt/β-catenin signaling pathways in hippocampal formation of neonatal rats
XAV939 purchased from AbMole
Cell Experiment | |
---|---|
Cell lines | B-T549, MDA-MB-231, HCC-1143 and HCC-1937 cell lines |
Preparation method | Cell viability assay. Cells were seeded at 20,000 cells/well into 96-well plates. After overnight incubation, cells were treated with DMSO or each Wnt inhibitor (iCRT-3, 75 μM; iCRT-5, 200 μM; iCRT-14, 50 μM; IWP-4, 5 μM and XAV-939, 10 μM) for 48 hours. Cell viability was determined using the Cell Titer-Glo luminescent cell viability assay kit (Promega) according to the manufacturer’s instructions. Luminescence was measured using FLUOstar microplate reader. All treatments were performed in triplicate, and each experiment was repeated three times. |
Concentrations | 10 μM |
Incubation time | 48 hr |
Animal Experiment | |
---|---|
Animal models | bleomycin-induced dermal fibcrosis mice model |
Formulation | 10% DMSO / 90% normal saline |
Dosages | 2.5 mg/kg, four times a day |
Administration | Intraperitoneal injection |
Molecular Weight | 312.3 |
Formula | C14H11F3N2OS |
CAS Number | 284028-89-3 |
Solubility (25°C) | DMSO 11 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
Related Wnt/beta-catenin Products |
---|
(9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide
(9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide is a macamide isolated from Maca (Lepidium meyenii Walp). (9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide induces mesenchymal stem cells osteogenic differentiation and consequent bone formation through activating the canonical Wnt/β‐catenin signaling pathway. |
F7H
F7H is a Frizzled receptor FZD7 antagonist with IC50 of 1.25 μM. F7H is a potent ligand for the FZD7 transmembrane domain (TMD). |
UU-T02
UU-T02 is a novel potent, selective small-molecule inhibitor of β-Catenin/T-cell factor protein-protein interaction, with a Ki of 1.36 μM. UU-T02 inhibits canonical Wnt signaling. |
Wnt/β-catenin agonist 1
Wnt/β-catenin agonist 1 is a Wnt/β-catenin signalling pathway agonist, with an EC50 of 0.27 μM. |
Calphostin C
Calphostin C (PKF115-584) is a small molecule inhibitor of Wnt/beta-catenin/lef-1 signaling. Calphostin C is also a potent and specific inhibitor of protein kinase C. PKF115-584 efficiently killed CLL cells (LC(50)<1 microM), whereas normal B cells were not significantly affected. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.